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INTRODUCTION
Advancement in weapons design has led to the introduction of several potentially toxic metals, such as depleted uranium (DU), onto the battlefield. The Persian Gulf War in 1991 saw the first combat use of DU kinetic penetrator munitions, and their success against enemy armor was dramatic. The demonstrated effectiveness of DU munitions in the first Gulf War has led other nations, some not friendly to the United States, to adopt these weapons into their own arsenals. Other types of kinetic energy penetrators use heavy-metal tungsten alloys (WA) in place of DU. In future conflicts, the United States will have to deal with an increased number of casualties from the use of these weapons. Because both DU-and WA-based munitions are relatively recent additions to the list of militarily relevant metals, little is known about the health effects of these metals after internalization as embedded shrapnel. This study was designed to assess the carcinogenic and immunotoxic potential of DU and WA using the Fisher 344 rat model and modified National Toxicology Program protocols for such studies. Responses to the test metals are being compared to responses to tantalum, a biologically inert metal that serves as a negative control and nickel, a known heavy-metal toxin and carcinogen that serves as a positive control. This research addresses the DOD effort to understand the potential health risks associated with DU and WA exposure in order to develop appropriate medical treatment protocols for personnel wounded by fragments of these metals.
BODY

Statement of Work
This study is an assessment of the immunotoxic and carcinogenic potential of embedded fragments of DU and WA in laboratory rats. Responses to these metals are compared to the biologically inert metal, tantalum, and the carcinogen and heavy-metal toxin, nickel. For these experiments, rats are implanted with tantalum pellets alone (metal control group), a mixture of DU and tantalum pellets (low DU group), DU pellets alone (high DU group), a mixture of WA and tantalum pellets (low WA group), or WA pellets alone (high WA group). There is also a non-surgical control group and a positive carcinogenesis control group implanted with nickel pellets. Animals will be euthanized and various analyses performed 1, 3, 6, 12, 18 , and 24 months after implantation. Analyses include histopathological examination and metal determinations as well as assessments of mutagenicity and cytogenicity. A battery of immunological tests designed to assess both humoral and cell-mediated immunity, as well as the innate immune response, will be conducted at 1, 3, 6, and 12 months.
Progress to Date
Because of technical and personnel issues, primarily concerning the metal measurement aspect of the project, we requested and received a one-year, no-cost extension of the project. Implantation surgery, euthanasia, and necropsy of all experimental groups are complete. General health parameters (body weight, hematological assessments, serum chemistries, etc.) and tumor incidence have been reported (Year 3 Annual Report). All immunotoxicity assessments have been completed. Serum and urine mutagenicity measurements have been completed. In Year 5, the primary task will be to finish the metal analysis of the experimental tissue samples and compile and statistically analyze that data. The data collected from the genotoxicity portion of the project will also be statistically analyzed. A timeline for the remaining Year 5 work is presented below, as are detailed results corresponding to the various project tasks. Work was substantially completed and reported in the Year 3 Annual Report. In Year 4, further histopathological characterization of the WA-induced rhabdomyosarcomas was undertaken. There was little or no capsule formation around the WA pellet or associated tumors ( Fig. 1 -Appendices) . The tumor infiltrated into the skeletal muscle, separating and isolating individual myofibers. Eventually degeneration of the myofibers , with internalization of nuclei, was observed (Figs. 2 and 3 -Appendices). We found that cell pattern and morphology was variable, even within the same tumor (Fig. 4 -Appendices) . Cell patterns ranged from distinct spindle cell in streams with strap-like cells to pleomorphic spindle cell pattern, to a round cell, spider cell and giant cell patterns, more similar to embryonal rhabdomyosarcomas (Figs. 5-9 -Appendices).
The immunohistochemical analysis (Altmannsberger et al., 1985) of the WAinduced leg tumors, as well as the resulting metastatic lung tumors were reported in the Year 3 Annual Report and are also described in detail in our publication in Environmental Health Perspectives (Kalinich et al., 2005 -Appendices) .
As also reported in the Year 3 report, rats implanted with 20 pellets of WA (high dose group) exhibited characteristics of polycythemia (elevated red blood cell counts, splenomegaly). Shown in Fig. 10 (Appendices) is a cross section of the spleen from one of these rats. There is a noticeable increase in nucleated red blood cells and a mild decrease in the myeloid:erythroid ratio in the red pulp indicative of eyrthroid hyperplasia.
No tumors, resulting from pellet implantation, were observed in the tantalum, low DU, or high DU groups at the 1-, 3-, 6-, 12-, 18-, or 24-month time points. Gross necropsies of these groups revealed no abnormalities. The 18-and 24-month animals, in all surviving groups, exhibited health problems associated with old age (e.g., testicular cancer, benign abdominal growths, etc.). These health problems were not associated with a particular treatment group. They were found across all experimental groups. As a result of these age-related health problems, many of the 18-and 24-month animals were euthanized before reaching their experimental endpoint; however, no abnormalities associated with the tantalum or DU implanted pellets were observed. During Year 4 we experienced significant technical problems with the inductively coupled plasma mass spectrometer (ICP-MS) used to conduct the metal measurements on our experimental samples. In addition, the individual responsible for operating this instrument is leaving the Institute. However, during Year 4, we completed the analytical preparation of the several thousand tissue samples collected in this project. Personnel associated with the grant were recently training in the operation and maintenance of the ICP-MS and have assumed the instrument operator's responsibilities. Shortly after completing training, we successfully resolved the issue of matrix effects (particularly in bone, liver, and kidney) that originally hindered our ability to accurately assess nickel and cobalt levels. Due to the extremely large number of samples to be analyzed (approximately 10000), this task will take the greater part of the next year, with the data to be presented in the final report.
Task 3 -Assess the genotoxicity and mutagenicity after chronic in vivo exposure to DU or WA.
All samples designated for genotoxicity assessment have been processed. The data is currently being compiled and statistically analyzed. Representative chromosome spreads, used for chromosomal analysis, are shown in Fig. 11 of the Appendices. All genotoxicity data will be presented in the final report.
The mutagenicity assessment of serum samples from the 18-month experimental groups has been completed. There was no indication that serum from any of the experimental groups was mutagenic ,when assayed by the Ames bacterial reversion assay (Appendices -Table 1 ). Because the 24-month experimental groups were euthanized at various times less than the full 24 months, no valid statistical comparison of the different experimental groups could be made concerning the mutagenic potential of that serum. As reported in the Year 3 Annual Report, no urine was collected from the 18-and 24-month animals because, due to the declining health of the rodents, we opted against stressing the animals further by housing them in the metabolic cages required for urine collection.
Task 4 -Determine the effect of embedded DU and WA on the organs of the immune system.
Substantially all the results pertaining to this task were presented in the Year 3 Annual Report, except for the flow cytometric analysis data which we are reporting here. Flow cytometric analysis of peripheral blood lymphocytes, splenocytes, and thymocytes was conducted in order to investigate any changes, as a result of prolonged exposure to embedded DU or WA, in the subpopulations of cells that comprise these immune system organs. Using the methods of Flaherty et al. (1997) and Capri et al. (2000) , we determined the CD4 and CD8 subpopulations in isolated thymocytes; the cytotoxic Tcell, T-helper cell, and the naYve and activated subpopulation of CD4 and CD8 cells in peripheral blood; and the T cell, B cell, cytotoxic T cell, T helper cell, NK cell, and putative monocyte levels in isolated splenocytes (Tables 2-5 -Appendices).
For DU-implanted rats, the number of splenic NK cells were decreased 1 month post-implantation, but had returned to normal by 3 months post-implantation. All assessments at every other time point were not statistically different than control, with the exception of the 6-month splenic NK cells for the low-dose DU group which were significantly higher than control. However, at 12 months post-implantation there was no significant difference and the high-dose DU group showed no such changes.
For WA-implanted rats, there were numerous and consistent changes in immune cell subpopulations in both peripheral blood and spleen. High-dose WA-implanted rats showed significant decreases in peripheral blood cytotoxic T cells, T helper cells, and na'fve CD4 and CD8 cells starting as early as 1 month post-implantation. Both the lowand high-dose WA rats demonstrated lower splenic B cell levels, as well as lower NK cell levels (as did both DU groups) at 1 month post-implantation. The peripheral blood subpopulation changes persisted in the high-dose WA rats at 3 months post-implantation. The splenic B cell levels returned to normal in both WA groups, but splenic NK cell levels remained depressed. By 6 months post-implantation, all WA rats had developed tumors at the pellet implantation site and were reaching the criteria for euthanasia. Not surprisingly, all peripheral blood flow cytometric parameters were significantly lower in both the low-and high-WA animals as compared to control. Somewhat surprisingly, values for the various immune system cell subpopulations in the spleen were not statistically different from control, except for splenic NK cell levels which had risen significantly higher. No WA animal survived to the 12 month time point.
Interestingly, there were no significant changes in CD4/CD8 thymocyte subpopulations between the various treatment groups at any of the time points assayed. Also, due to a computer hard drive problem, the peripheral blood and splenic flow cytometric analysis for non-surgical 6-month animals was lost. For this time point, statistical comparison was done using the tantalum control animals as the "control" group. There were no statistical differences between the non-surgical group and the tantalum control group at any time point for any of the parameters assessed, except for 1 month splenic NK cell levels. Since this was observed in all implantation groups, we believe it is a result of the surgery itself. However, the tantalum control levels, although statistically lower than the non-surgical control levels, were still significantly higher than the levels found in both DU and WA groups. This may be the result of toxicity of the metals specific to those implants. Two additional manuscripts are in preparation.
CONCLUSIONS The project encountered some delays this year when we experienced significant technical issues with our inductively coupled plasma mass spectrometer (ICP-MS), used for metal analysis of our tissue samples. In addition, we lost two key personnel involved in the project to retirement. As a result, we requested a one-year, no-cost extension for the project, which was granted (Letter -Appendices). During this year we have had several additional personnel trained in the operation and maintenance of the ICP-MS and they have assumed the departing instrument operator's responsibilities. Metal analysis of the several thousand tissue samples collected is the most important task remaining. This year, all samples were prepared for analysis and several technical issues with the analytical procedure successfully resolved. Metal analysis is currently underway and no major issues have been encountered by the recently trained operators. We expect that it will take 3 to 4 months to assay all of the samples, with additional time required for data compilation and statistical analysis. We expect that all work will be completed well before the one-year extension ends. The only other remaining work involves compilation and analysis of our genotoxicity data. We will also continue our histopathological analysis of experimental tissues. We plan to store these tissues in order that, in the future, additional testing can occur as technical methods become more advanced.
As noted earlier, all experimental animals have been implanted and reached their euthanasia time points. No pellet-associated tumors were found in tantalum-or DUimplanted animals. However, rapid and aggressive tumor development occurred at the implantation sites in the WA groups. This raises significant concern since heavy-metal tungsten alloys are being used as replacements for DU in armor penetrators. In fact, many countries, some unfriendly to the U.S., already possess tungsten munitions. As a result, future combat could produce large numbers of U.S. personnel with tungsten fragment injuries with military surgeons not having the best information available to deal with those injuries.
All immuntoxicity assessments have been completed and reported. The majority of the data were reported last year. This year we have shown the high-dose WAimplanted rats exhibited significant alterations in the distribution of lymphocyte subpopulations in both peripheral blood and spleen as early as one month after pellet implantation. The perturbations continued throughout the life of the animal. Low-dose WA-implanted animals showed the same effects later in life, indicating a potential deleterious effect on the immune system with increasing amounts of embedded WA.
It should be pointed out that the tungsten alloy we used consisted of tungsten, nickel, and cobalt. Other tungsten alloys, tungsten/nickel/iron in particular, are also being used to produce armor penetrating munitions. Because of the lack of information on the health effects of embedded fragments composed of these types of mixtures, we strongly recommend funding be made immediately available for an additional study to investigate potential tumor development patterns for implanted tungsten/nickel/iron, as well as for the individual metals alone and in various combinations. With these data, a detennination of the carcinogenic potential of the individual metals can be made, as well as a determination of any synergistic effects that may occur when the various metal are present together. With these results, a comparison of the various alloys can be made and the exposure risk put into perspective. Investigations on hard-metal disease have Continuing concern regarding the potential health and environmental effects of depleted uranium shown that either tungsten carbide or Co and lead has resulted in many countries adding tungsten alloy (WA)-based munitions to their alone has limited toxicity on lung tissue battlefield arsenals as replacements for these metals. Because the alloys used in many munitions are (Lasfargues et al. 1992) . However, when relatively recent additions to the list of militarily relevant metals, very little is known about the combined, the tungsten carbide/cobalt mixhealth effects of these metals after internalization as embedded shrapnel. Previous work in this laboture acts synergistically to increase the ratory developed a rodent model system that mimicked shrapnel loads seen in wounded personnel observed toxicity. It is not known whether from the 1991 Persian Gulf War. In the present study, we used that system and male F344 rats, this is due to the combined toxicity of the implanted intramuscularly with pellets (1 mm x 2 mm cylinders) of weapons-grade WA, to simutungsten carbide/cobalt mixture or to an late shrapnel wounds. Rats were implanted with 4 (low dose) or 20 pellets (high dose) of WA.
increase in the bioavailability of the known Tantalum (20 pellets) and nickel (20 pellets) served as negative and positive controls, respectively. toxicant, Co (Lison and Lauwerys 1997). The high-dose WA-implanted rats (n = 46) developed extremely aggressive tumors surrounding
In vitro studies investigating malignant transthe pellets within 4-5 months after implantation. The low-dose WA-implanted rats (n = 46) and formation of immortalized human cells by nickel-implanted rats (n = 36) also developed tumors surrounding the pellets but at a slower rate.
mixtures of tungsten, Ni, and Co suggest a Rats implanted with tantalum (n = 46), an inert control metal, did not develop tumors. Tumor synergistic effect that greatly exceeds the yield was 100% in both the low-and high-dose WA groups. The tumors, characterized as higheffects of the metals individually (Miller et al. grade pleomorphic rhabdomyosarcomas by histopathology and immunohistochemical examina-2001, 2002) . tion, rapidly metastasized to the lung and necessitated euthanasia of the animal. Significant Advancements in metallurgy have led the hematologic changes, indicative of polycythemia, were also observed in the high-dose WAmilitary of many nations to replace DU in implanted rats. These changes were apparent as early as 1 month postimplantation in the highsome armor-penetrating munitions and lead dose WA rats, well before any overt signs of tumor development. These results point out the need in small-caliber ammunition with various for further studies investigating the health effects of tungsten and tungsten-based alloys, alloys of tungsten. One motivation for such a Key words: cobalt, embedded fragment, nickel, rat, rhabdomyosarcoma, tungsten, tungsten alloy, replacement is widespread public concern Environ Health Perpect 113: 729-734 (2005) . doi:10.1289/ehp.7791 available via http://dx.doi.org/ about the health and environmental impact of [Online 15 February2005] continued use of these metals. However, to our knowledge, none of these militarily relevant WAs has been tested for potential health Tungsten has been used for many years in a results in tumor formation in 40% of the rats effects, especially as embedded shrapnel. 
Materials and Methods
been used in human prostheses (Hockley 24 months; however, because of the rapid Rodents. Male F344 rats (6 weeks of age ; et al. 1990; Johansson et al. 1990 ). Nickel, a tumor development, no WA-or Ni-implanted Harlan, Frederick, MD) were maintained in a known carcinogen, was used as a positive con-rat survived much past 6 months postfacility accredited by the Association of trol (Costa and Klein 1999; Kasprzak et al. implantation. Final survival data therefore Assessment and Accreditation of Laboratory 2003). Rats were implanted at 9 weeks of age. included rats originally assigned to the 12-, Animal Care in accordance with the Guide for For the pellet implantation procedure, anes-18-, and 24-month experimental groups, the Care and Use of Laboratory Animals thesia was induced by continuous administra-whose animals died earlier than those desig-(Institute of Laboratory Animal Resources tion of isoflurane using an open circuit system nated time points. This resulted in group sizes 1996). All procedures, including euthanasia with a scavenger/recapture system. All surgery of n = 46 for the Ta and both WA groups, and criteria (Tomasovic et al. 1988) , were was done using aseptic techniques. After the n = 36 for the Ni group. Hematologic assessapproved by the Armed Forces Radiobiology surgical sites were clipped and cleansed with ments were conducted on the separate 1-, 3-, Research Institute's (AFRRI) Animal Care Betadine, an incision was made through the and 6-month WA implantation groups. and Use Committee. Upon arrival, animals skin to expose the gastrocnemius muscle.
Pathology. At various times postimplantawere screened for common rodent pathogens. Pellets were implanted in the muscle, spaced tion or when moribund, rats were euthanized Rats were pair-housed in plastic microisolator approximately 1.5 mm apart on the lateral by isoflurane overdose. A complete gross cages with hardwood chips for bedding and side of each leg. The incision was closed with pathology examination was conducted, noting fed a certified NTP-2000 (Quality Lab sutures and tissue adhesive. Rats were closely any abnormalities, and tissues were collected Products, Elkridge, MD) diet (Rao 1996) monitored after surgery until they were for analysis. Weights of representative tissues, with acidified water provided ad libitum. ambulatory. An analgesic (buprenorphine including spleen, thymus, testes, kidney, and Animals were on a 12-hr light/dark cycle with hydrochloride; Reckitt and Colman, Hull, liver, were determined and normalized to no twilight and were weighed weekly.
UK) was administered preoperatively and body weight. Tissues for histopathology were Pellets. All metal pellets were cylinders then as needed postoperatively. The surgical fixed in buffered formalin, processed and 1 mm in diameter and 2 mm in length.
sites were examined daily for signs of inflam-embedded in paraffin, cut at 5-6 pm, Nickel (99.995% metallic Ni) and tantalum mation, infection, and local metal toxicity, mounted, and stained with hematoxylin and (99.95% Ta) pellets were purchased from Experimentalgroups. Our pellet implanta-eosin (H&E). Immunohistochemical analysis Alfa Aesar (Ward Hill, MA). WA pellets were tion groups included Ta (negative control), was conducted on 5-pm-thick sections of forfabricated by Aerojet Ordnance Tennessee WA (both a low-and high-dose group), and malin-fixed, paraffinized tissue. After deparaf-U(onesborough, TN) using standard kinetic Ni (positive control). The original euthanasia fination and rehydration, nonspecific binding energy penetrator production processes. An time points were to be 1, 3, 6, 12, 18 , and was blocked with Power Block (Biogenex, San average WA pellet weighed 27.5 mg and consisted of 91.1% tungsten, 6.0% Ni, and 2.9% Co. Ni and Ta pellets weighed 14 mg and A B 27 mg, respectively. Before implantation surgery, all pellets were cleaned and chemically sterilized (Pellmar et al. 1999) .
Pellet-implantation surgery. A rodent model system (AFRRI 1996) , originally developed to mimic DU shrapnel loads seen in wounded personnel from the 1991 Persian Gulf War, was used to investigate the health effects of retained WA shrapnel. All rats were implanted with a total of 20 pellets split evenly between each hind leg. Experimental groups included Ta (negative control, (n = 46) survived well beyond 12 months with respectively. The mean survival time of the After blocking with hydrogen peroxide, the no apparent health problems. All rats in the high-dose WA animals was significantly tissue sections were labeled with peroxidase-high-and low-WA and the Ni groups develshorter than that of the low-dose WA-or Niconjugated streptavidin (Biogenex) and oped tumors and were euthanized upon implanted animals [analysis of variance aminoethyl carbazole (AEC; Biogenex) was becoming moribund. Rats in the high-dose (ANOVA) followed by Dunnett's test, used as a chromogen. Slides were then counter-WA group (n = 46) survived the least amount p < 0.051. The mean survival times of the lowstained with hematoxylin and mounted.
of time (mean survival time ± SD = 21.8 ± dose WA-and the Ni-implanted animals were Hematology. At euthanasia, we obtained 2.1 weeks). Nickel-implanted animals (n = 36) not statistically different from each other. The blood for hematologic assessments from the abdominal aorta of isoflurane-anesthetized rats using a heparinized needle and sample A tubes containing EDTA (Becton-Dickinson, Franklin Lakes, NJ). We determined white and red blood cell counts; hemoglobin;
hematocrit; mean corpuscular volume, hemoglobin, and hemoglobin concentration; red cell distribution width; platelet counts and volume; and neutrophil, lymphocyte, monocyte, cosinophil, and basophil counts with a Bayer Advia 120 Hematology Analyzer (Bayer Diagnostics, Terrytown, NY).
Results
All rats tolerated the pellet implantation procedure with no apparent adverse effects. The v--incision sites were examined daily; no rat C showed any signs of infection from the surgery, or any discomfort postoperatively. Body weights were recorded weekly. Once they had recovered from the surgical procedure, all rats gained weight at equivalent rates. However, in the first week after the pellet implantation surgery, the rate of weight gain by the Ta and low-dose WA rats was slower than normal, and high-dose WA and Ni rats lost weight. This was followed by large weight gains in postimplantation week 2 in all experimental groups. There were no statistical dif-" ferences in rate of body weight gain between any of the groups throughout the remaining T experimental period. As previously reported,
• ,E i results reported here are part of a larger study bronchioles, expanding the alveolar septae, of Ta-implanted rats. High-dose WA rats euththat also investigated the health effect of and replacing alveolar spaces. These neo-anized 1 and 3 months after pellet implantation embedded DU fragments. We did not observe plastic cells have a high mitotic rate and are also exhibited significantly elevated spleen:body tumor formation in the DU-implanted rats often seen surrounding or occluding arterioles weight ratios compared with the appropriate (Kalinich JF, Miller AC, McClain DE, (Figure 4C) . Figure 4D shows that the Ta-implanted control rats (Tables 2 and 3) . unpublished data). metastatic neoplastic cells, as well as vascular Thymus:body weight ratios, however, were not Upon euthanasia, the animals underwent and airway smooth muscle, are strongly posi-significantly different. At 3 months postnecropsy, and tissue samples were taken for tive for the muscle marker desmin.
implantation, the kidney:body weight ratio in various analyses. Figure 2 shows the appearSelected hematologic and organ weight high-dose WA rats was significantly higher than ance of the hind limb of rats implanted with parameters for euthanized rats are shown in that in Ta rats, but it was significantly lower Ta (Figure 2A) or WA ( Figure 2C ) for 26 and Table 1 . The Ta data were obtained from rats at 1 month postimplantation. There were no 23 weeks, respectively, before surgical removal implanted with Ta pellets for 6 months. The 1-and 3-month Ni-implanted groups. of the implanted pellets. The gross anatomy of data for the remaining groups were obtained WA-implanted animals had significant the Ta-implanted leg is normal, whereas in the at the time the rats became moribund because changes in a number of hematologic parame-WA leg the tumor is dearly visible. Upon dis-of tumor development. No significant differ-ters. Rats implanted with 20 WA pellets section, no obvious abnormalities were ences in organ/body weight ratios were seen exhibited significant increases in white blood observed in the Ta-implanted animals, and the for the low-dose WA-or Ni-implanted ani-cell counts, red blood cell counts, hemoglobin, pellets could be easily removed ( Figure 2B ). mals compared with Ta-implanted control and hematocrit levels compared with Ta conHowever, in the WA-implanted animals, the rats. However, high-dose WA-implanted rats trol rats, whereas rats implanted with 20 Ni pellets were surrounded by tumor ( Figure 2D ). showed significantly higher spleen:body weight pellets had significant decreases in red blood In many cases, the interior of the tumor had ratios compared with control rats. In addition, cell counts, hemoglobin, and hematocrit levbecome necrotic and/or hemorrhagic. Similar thymus:body weight ratios were decreased in els (Table 1) . Hematologic parameters from tumors were found for both WA-and Ni-the high-dose WA rats. Because the spleen and low-dose WA rats were not statistically differimplanted animals. In low-dose WA animals, thymus are integral components of the immune ent from controls. Statistically significant tumors were found surrounding the WA pel-system, these changes suggest that embedded increases in red blood counts, hemoglobin, lets only. No tumors were found surrounding WA, at certain levels, may be immunotoxic. and hematocrit levels were observed in highimplanted Ta pellets. Implanted WA pellets The kidney:body weight ratio for high-dose dose WA animals as early as 1 month after rapidly oxidized and had a slightly eroded WA rats was also significantly higher than that pellet implantation and persisted throughout appearance. Ta pellets did not have an eroded appearance even after implantation for 6 months. However, despite their appearance, the WA pellets lost < 5% of their mass over this time.
Tumor tissue was histopathologically K examined and characterized. Figure 3A shows the neoplastic cells surrounding the site of the implanted WA pellet. These cells infiltrated preexisting skeletal muscle fibers. Fibers that became isolated by this process degenerated and demonstrated a loss of cross-striations and internalization of nuclei ( Figure 3B,C) . Neoplastic cells were pleomorphic with marked anisocytosis and anisokaryosis A ( Figure 3D ). In addition, an extremely high mitotic rate was observed in these cells, and bizarre mitoses were present. Immunohistochemical staining was used to determine the origin of these neoplastic cells. The cells were strongly positive for desmin ( Figure 3E,F) , suggesting a skeletal muscle origin.
In the WA-implanted animals, the tumors had metastasized to the lung. None of the Niimplanted animals showed signs of lung 0 metastases, although some exhibited endogenous histiocytic lipid pneumonia not seen in the WA animals. Figure 4A shows numerous _Zý z metastatic foci in the lungs of a high-dose WA rat. These multiple masses obscure >50% of the lung surface and up to 90% in V•x.
the latter stages of development. Figure 4B shows a photomicrograph of these pulmonary 
